CureSearch to Award 12 Young
Investigator Grants
Letters of Intent for Late Effects and Survivorship, Rare Tumors, Acute Myeloid Leukemia, and Lymphomas now being accepted


As part of the CureSearch Investigational Research Initiative, CureSearch for Children's Cancer this year will provide 12 $100,000 grants for scientists focused on innovative research offering the greatest potential to design treatments and improve outcomes for children with difficult-to-treat cancers.

Working with a panel of children's cancer research experts, CureSearch identified 12 areas of study that present the highest risk with the poorest outcomes for children with cancer. "We recognize that for many types of children's cancer, survival rates have not significantly increased in the past two decades," said Stuart Siegel, MD who is Chair of the CureSearch Board of Directors and Director of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles. "By strategically placing funds in the hands of researchers focused on these cancers, we hope to help move the needle so that more children have a chance for a cure."

Letters of intent for grant applications in late effects and survivorship, rare tumors, acute myeloid leukemia, and lymphomas are now being accepted through October 19 and are available on Proposal Central at https://proposalcentral.altum.com/.

Applicants who received approval of their Letters of Intent for Adolescents and Young Adults, Liver Tumors, Soft Tissue Sarcomas, and CNS Tumors must submit full applications by November 23.

For more information on children's cancer research and funding opportunities, click here.

Shelby Hammond
Communications Manager
Email Shelby
(240) 235-2205



Childhood Cancer

Medical Information

Research

Coping with Cancer

Get Involved

About Us